The level of fasting C-peptide was significantly decreased (p < 0.0001) whereas the fasting insulin was elevated in T1DM patients compared with both MODY2 and control (p = 0.0034), indicating the islets dysfunction and insulin treatment in T1DM patients. Here, INS is linked to type 1 diabetes mellitus.